Sanofi and Re­gen­eron de­but next gen­er­a­tion in Dupix­en­t's asth­ma cam­paign

The lead­ing TV ad-spend­ing drug brand is get­ting a cam­paign re­fresh for one of its in­di­ca­tions. Sanofi and Re­gen­eron re­newed the ef­fort for Dupix­ent in asth­ma with light-heart­ed hu­mor around every­day mo­ments.

Peo­ple in the new com­mer­cial lift lug­gage, sing in the show­er, cry dur­ing a sad movie and just sleep while a voiceover asks, “When you can breathe bet­ter, what isn’t bet­ter?”

There hasn’t been a new TV com­mer­cial for Dupix­ent’s in­di­ca­tion for mod­er­ate-to-se­vere asth­ma since May 2023, ac­cord­ing to re­al-time TV ad track­er iS­pot.tv. Sanofi and Re­gen­eron spent $125 mil­lion on asth­ma-fo­cused na­tion­al buys last year, ac­cord­ing to iS­pot, which was down from $134 mil­lion in 2022 and $141 mil­lion in 2021.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER